Global Cell and Gene Therapy Markets Report 2024-2028 Featuring Main Players - Mallinckrodt, Vericel, Gilead Sciences, Pharmicell, and Bristol-Myers Squibb
03 avr. 2024 03h10 HE
|
Research and Markets
Dublin, April 03, 2024 (GLOBE NEWSWIRE) -- The "Global Cell and Gene Therapy Market" report has been added to ResearchAndMarkets.com's offering. The Global Cell and Gene Therapy Market is...
Asia-Pacific Gene Editing Technology Research Report 2024
29 févr. 2024 10h03 HE
|
Research and Markets
Dublin, Feb. 29, 2024 (GLOBE NEWSWIRE) -- The "Asia-Pacific Gene Editing Technologies Market: Analysis and Forecast, 2023-2032" report has been added to ResearchAndMarkets.com's offering.The...
Europe's Gene Editing Technologies Market, Valued at $370 Million in 2023, is Set to Reach $3.26 Billion by 2032 - Country-Specific Insights for Agriculture & Biomedical Applications Unveiled
30 janv. 2024 07h50 HE
|
Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "Europe Gene Editing Technologies Market: Analysis and Forecast, 2023-2032" report has been added to ResearchAndMarkets.com's offering.The Europe gene...
Un rapport d’experts détaille les problèmes scientifiques et réglementaires posés par les procédés génétiques de lutte antiparasitaire
08 nov. 2023 06h00 HE
|
The Council of Canadian Academies (CCA)
Ottawa (Ontario), Nov. 08, 2023 (GLOBE NEWSWIRE) -- Les procédés d’édition génomique ont des applications prometteuses dans la lutte antiparasitaire, mais posent des problèmes importants en matière...
Expert report details the scientific and regulatory challenges of genetic pest-control technologies
08 nov. 2023 06h00 HE
|
The Council of Canadian Academies (CCA)
Ottawa, ON, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Gene-editing technologies hold promising applications for pest control, but pose critical risk-management issues, according to Framing Challenges and...
Verve and Lilly Relationship Expands to Include Verve’s In Vivo Gene Editing Programs Targeting PCSK9 and ANGPTL3
31 oct. 2023 06h01 HE
|
Verve Therapeutics
BOSTON, Oct. 31, 2023 (GLOBE NEWSWIRE) -- Verve Therapeutics, Inc., a clinical-stage biotechnology company pioneering a new approach to the care of cardiovascular disease with single-course gene...
World-Leading Gene Editing Technology Unveiled in United Kingdom
23 oct. 2023 12h38 HE
|
Research and Markets
Dublin, Oct. 23, 2023 (GLOBE NEWSWIRE) -- In a momentous stride toward the future of agriculture, scientists have recently achieved a remarkable breakthrough in the realm of gene editing. The...
Gene Editing Market to Be Valued USD 36.4 Billion by 2032, North America in the Lead - Marketresearch.biz Report
23 oct. 2023 07h10 HE
|
MarketResearch.biz
New York, Oct. 23, 2023 (GLOBE NEWSWIRE) -- The gene editing market which was valued at USD 7.2 billion in 2022 is expected to witness a CAGR of 18.1%, from 2023 to 2032. It is expected USD 36.4...
US Gene Editing Market Poised for Unprecedented Growth: Rice University's Breakthrough Technology Shines
10 oct. 2023 10h08 HE
|
Research and Markets
Dublin, Oct. 10, 2023 (GLOBE NEWSWIRE) -- In the midst of remarkable discoveries in gene editing, researchers at Rice University have unveiled a groundbreaking improvement to traditional CRISPR...
Gene Synthesis Market to Hit USD 8.3 Billion by 2032 || Academic & Government Research Segment - Revenue Share of 51%
12 sept. 2023 09h21 HE
|
Market.Us
New York, Sept. 12, 2023 (GLOBE NEWSWIRE) -- According to a recent report by Market.us, the Global Gene Synthesis Market size is expected to be worth around USD 8.3 Billion by 2032 from USD 1.7...